 |
|
 |
      
|
Barry Reisberg, M.D. Clinical Director Dr. Reisberg’s studies have resulted in descriptions of the characteristic clinical course of Alzheimer’s disease. These descriptions in the form of scales such as the Global Deterioration Scale (GDS) and the Functional Assessment Staging (FAST) are measures widely used around the world. He has also described many of the psychiatric symptoms of Alzheimer’s disease and these descriptions, incorporated into his BEHAVE-AD scale, have been used to demonstrate the utility of drug treatments of these symptoms in worldwide studies. Recently, he directed national studies which have uncovered a new chemical messenger approach to the treatment of Alzheimer’s using, in large part, the scientific assessment measures which he has pioneered. His research has also recently uncovered a new fundamental biologic process, which he has termed "retrogenesis", which occurs in Alzheimer’s and other dementing disorders. The retrogenesis process explains the nature of the clinical symptoms of AD and associated management needs and provides a new direction for fundamental treatment investigation. Dr. Reisberg has contributed to more than 200 scientific publications. He is the author of A Guide to Alzheimer’s Disease and editor of a reference text, Alzheimer’s Disease, both published by Macmillan. Dr. Reisberg has served on the Medical and Scientific Advisory Board of the Alzheimer’s Association (USA) and serves on the Medical and Scientific Advisory Board of Alzheimer’s Disease International (ADI). He has served as President of the International Psychogeriatric Association. In this capacity, he has presided over meetings in Beijing, China; Berlin, Germany; Istanbul, Turkey; and the largest congress ever held in his field of geriatric psychiatry, in Vancouver, Canada.
|
|
About
the ADRC| For Patients & Families
| For Professionals | Programs
& Services
|
|
 Silberstein Aging & Dementia Research Center New York University School of Medicine © 2002 New York University Ethics and Disclaimer |
  |
 |
 |
 |
Barry
Reisberg, M.D. is a psychiatrist, geriatric psychiatrist and psychopharmacologist
who is a leading expert in Alzheimer’s disease and related areas.
For the past two decades, Dr. Reisberg has served as the Clinical Director
of NYU’s Aging and Dementia Research Center and has directed, as
Principal Investigator, U.S. National Institutes of Health sponsored
studies of Aging and Alzheimer’s disease. He is Professor of Psychiatry
at the New York University School of Medicine and Adjunct Professor
at the Center for the Study of Aging at the McGill University in Montreal,
Canada.
